NCT03418610View on ClinicalTrials.gov

Azelaic Acid Foam 15% in the Treatment of Papulopustular Rosacea

PHASE4CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

December 6, 2017

Primary Completion Date

January 9, 2019

Study Completion Date

January 9, 2019

Conditions
Rosacea, Papulopustular
Interventions
DRUG

Azelaic Acid foam 15%

mild to moderate rosacea

Trial Locations (1)

29407

Clinical Research Center of the Carolinas, Charleston

Sponsors

Collaborators (1)

Bayer
All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

Clinical Research Center of the Carolinas

OTHER

NCT03418610 - Azelaic Acid Foam 15% in the Treatment of Papulopustular Rosacea | Biotech Hunter | Biotech Hunter